Top

Published in:

01-01-2021 | Metastasis | Case report

Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report

Authors: Takahiko Soma, Minato Yokoyama, Yusuke Uchida, Susumu Kirimura, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Yasuhisa Fujii

Published in: International Cancer Conference Journal | Issue 1/2021

Abstract

Surgical resection is commonly performed for augmented bladder cancer, yet an optimal treatment strategy for augmented bladder cancer with lymph node metastasis has not been established. Here, we report a case that achieved 7 years of survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis. Extended surgery could be a useful treatment option for locally advanced augmented bladder cancer including mesenteric lymph node metastasis.

Xavier B, Emmanuel C, Morgan R et al (2016) Risk of malignancy after augmentation cystoplasty: A systematic review. Neurourol Urodyn 35(6):675–682CrossRef

Jeffrey B, Hamilton T, Samantha R et al (2019) Bladder augmentation (enterocystoplasty): the current state of a historic operation. Curr Urol Rep 20(9):50CrossRef

Ali-El-Dein B, El-Tabey N, Abdel-Latif M et al (2002) Late uro-ileal cancer after incorporation of ileum into the urinary tract. J Urol 167(1):84–88PubMedCrossRef

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) Small Bowel Adenocarcinoma. Updated < 07/30/2019 > https://www.nccn.org/professionals/physician_gls/pdf/small_bowel.pdf. Accessed < 04/04/2020 > . [PMID: 31487687]

PDQ^® Adult Treatment Editorial Board. PDQ Small Intestine Cancer Treatment. Bethesda, MD: National Cancer Institute. Updated < 01/29/2019 > . https://www.cancer.gov/types/small-intestine/hp/small-intestine-treatment-pdq. Accessed < 04/04/2020 > . [PMID: 26389423]

Liang FX, Bosland MC, Huang H et al (2005) Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement. J Cell Biol 171(5):835–844PubMedPubMedCentralCrossRef

Rausch S, Lotan Y, Youssef RF (2014) Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma. Urol Oncol 32(1):32.e11–32.e16CrossRef

Gitlin JS, Wu XR, Sun TT et al (1999) New concepts of histological changes in experimental augmentation cystoplasty: Insights into the development neoplastic transformation at the enterovesical and gastrovesical anastomosis. J Urol 162:1096–1100PubMedCrossRef

Higuchi TT, Granberg CF, Fox JA et al (2010) Augmentation Cystoplasty and Risk of Neoplasia: Fact. Fiction and Controversy. J Urol 184(6):2492–2496PubMed

10.

Hamid R, Greenwell TJ, Nethercliffe JM et al (2009) Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urological conditions: is it necessary? BJU Int 104(3):392–395PubMedCrossRef

11.

Higuchi TT, Fox JA, Husmann DA (2011) Annual endoscopy and urine cytology for the surveillance of bladder tumors after enterocystoplasty for congenital bladder anomalies. J Urol 186(5):1791–1795PubMedCrossRef

12.

Rove KO, Husmann DA, Wilcox DT et al (2017) Systematic review of bladder cancer outcomes in patients with spina bifida. J Pediatr Urol 13(5):456.e1–456.e9CrossRef

13.

National Library of Medicine. Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma (BALLAD). ClinicalTrials.gov: 2015. https://clinicaltrials.gov/ct2/show/NCT02502370. Accessed 04/04/2020

Title: Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report
Authors: Takahiko Soma
Minato Yokoyama
Yusuke Uchida
Susumu Kirimura
Hajime Tanaka
Soichiro Yoshida
Yoh Matsuoka
Yasuhisa Fujii
Publication date: 01-01-2021
Publisher: Springer Singapore
Keywords: Metastasis
Cystectomy
Small Intestine Cancer
Small Intestine Cancer
Published in: International Cancer Conference Journal / Issue 1/2021
Electronic ISSN: 2192-3183
DOI: https://doi.org/10.1007/s13691-020-00442-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Three cases of seromucinous carcinoma of the ovary arising in endometriotic cysts

Gastric glomus tumor with a preoperative diagnosis by endoscopic ultrasonography-guided fine needle aspiration: a case report

An autopsy case of Trousseau’s syndrome with tumor thrombosis in unknown primary squamous cell carcinoma of the head and neck

Limb arteriolar vasculitis induced by pembrolizumab plus chemotherapy in a patient with lung cancer

Would extirpative pelvic surgery improve survival in gynecological metastases of lung cancer? Case report and review of the literature

A case of inferior right hepatic vein–right hepatic vein bypass with interrupted inferior vena cava compressed by focal nodular hyperplasia in caudate lobe

Keynote webinar | Spotlight on antibody–drug conjugates in cancer